AstraZeneca (LON:AZN) Stock Passes Above 200 Day Moving Average - What's Next?

Key Points

• AstraZeneca shares have recently crossed above their 200-day moving average of £108.93, trading as high as £115.86, indicating positive momentum in the stock.
• Wall Street analysts have mixed ratings, with Deutsche Bank maintaining a "hold" rating and a £110 price target, while Shore Capital and Berenberg Bank have set higher price targets of £135 and GBX 140, respectively.
• The company has a market capitalization of £222.19 billion, a P/E ratio of 31.65, and a relatively low beta of 0.17, indicating lower volatility compared to the market.

AstraZeneca PLC (LON:AZN - Get Free Report) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of £108.93 ($147.14) and traded as high as £115.86 ($156.50). AstraZeneca shares last traded at £115.83 ($156.46), with a volume of 2,064,943 shares traded.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a £110 price target on shares of AstraZeneca in a report on Wednesday, July 30th. Shore Capital reaffirmed a "buy" rating and set a £135 price target on shares of AstraZeneca in a research report on Tuesday, July 29th. Finally, Berenberg Bank restated a "buy" rating and set a GBX 140 price objective on shares of AstraZeneca in a report on Friday, May 16th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of GBX 9,660.

AstraZeneca Stock Up 0.4%

The company has a quick ratio of 0.59, a current ratio of 0.93 and a debt-to-equity ratio of 73.83. The stock has a fifty day moving average price of £107.24 and a two-hundred day moving average price of £108.93. The company has a market cap of £226.69 billion, a price-to-earnings ratio of 32.29, a P/E/G ratio of 0.86 and a beta of 0.17.

Insider Activity at AstraZeneca

In other news, insider Aradhana Sarin sold 9,563 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of £115.12, for a total transaction of £1,100,892.56. Insiders own 0.04% of the company's stock.

AstraZeneca Company Profile

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.